Last Price
132.64
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Market Cap
50 Billion
Shares Outstanding
383 Million
Avg Volume
3,849,516
Avg Price (50 Days)
109.35
Avg Price (200 Days)
98.53
PE Ratio
-8.51
EPS
-15.60
Earnings Announcement
01-Aug-2024
Previous Close
129.06
Open
129.76
Day's Range
127.8302 - 133.04
Year Range
62.55 - 142.79
Trading Volume
2,932,245
1 Day Change
2.80%
5 Day Change
9.88%
1 Month Change
28.27%
3 Month Change
50.14%
6 Month Change
73.57%
Ytd Change
17.94%
1 Year Change
5.66%
3 Year Change
-17.30%
5 Year Change
474.87%
10 Year Change
613.33%
Max Change
613.33%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
WorldWideInvestor
No one comment here?
2020-06-29 22:34